The mRNA Vaccines and Therapeutics Market is estimated at $3.43 billion in 2018. The Standardized Therapeutic Cancer mRNA Vaccines segment held a share of 35.47% in 2018 and is projected to grow with a CAGR of 9.77% in next ten years.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 184-page report you will receive 130 charts– all unavailable elsewhere.

The 184-page report provides clear detailed insight into the mRNA Vaccines and Therapeutics Market. Discover the key drivers and challenges affecting the market.

Download Free Sample Pages of this report

Report Scope
Revenue and growth
forecasts from 2019 to 2029 for the mRNA Vaccines and Therapeutics market

Revenue and growth forecasts from 2019 to 2029 for the mRNA Vaccines and Therapeutics market by type:

  • Standardized Therapeutic Cancer mRNA Vaccines
  • Individualized Therapeutic Cancer mRNA Vaccines
  • Therapeutic Infectious Disease mRNA Vaccines
  • mRNA Therapeutic for Other Diseases

Revenue and growth forecasts from 2019 to 2029 for the mRNA Vaccines and Therapeutics market by Mechanism of Action:

  • Bioengineered Vaccine
  • Gene Therapy (Gene Silencing/Suppression)
  • Gene Transcription (Protein Generation)
  • Cell Therapy
  • Monoclonal Antibody
  • Others

 Revenue and growth forecasts from 2019 to 2029 for the leading regional and national markets:

  • North America: the revenues are further broken down into the US and Canada
  • Europe: the revenues are further broken down into the UK, Germany, France, Italy and Spain
  • Asia-Pacific: the revenues are further broken down into China, Japan and India
  • Rest of the World: the revenues are further broken down into Brazil, Mexico, Russia and South Africa

Discussion and profiles of the leading players in the mRNA Vaccines and Therapeutics market:

  • Argos Therapeutics, Inc.
  • BioNTech AG
  • CureVac AG
  • eTheRNA Immunotherapies
  • ethris GmbH
  • In-Cell-Art
  • Moderna Therapeutics
  • Sangamo Therapeutics, Inc.
  • Tiba Biotech
  • Translate Bio, Inc.

Discussion on mRNA & Delivery Technologies covering Arcelis Technology, Flow Electroporation Technology, Hybrid mRNA Technology, Lipid Nanoparticle (LNP) mRNA Technology, Nanotaxi Technology, RNArt & RNAntibody Technology, UNA & LUNAR Technologies, RNActive Technology, Self-Amplifying mRNA (SAM) Technology, TriMix Technology

Qualitative analysis of factors that drive and restrain the mRNA Vaccines and Therapeutics market. Trends analysis of the mRNA Vaccines and Therapeutics market.

mRNA Vaccines and Therapeutics R&D pipeline analysis

Key Questions Answered by this Report:

  • How is the mRNA vaccines and therapeutics market evolving?
  • What is driving and restraining the mRNA vaccines and therapeutics market?
  • What are the market shares of the leading segments of the mRNA vaccines and therapeutics market in 2018?
  • What will be the main driver of the overall market from 2019 to 2029?
  • How will the market shares of the leading national markets change by 2029 and which country will lead the market in 2029?
  • How will the industry evolve during the period between 2019 and 2029?
  • Who are the leading companies in this market?